The reduction of tetrachloroethylene (PCE) and
trichloroethylene (TCE) catalyzed by vitamin B12
was
examined in homogeneous and heterogeneous (B12
bound to agarose) batch systems using titanium(III)
citrate as the bulk reductant. The solution and
surface-mediated reaction rates at similar B12
loadings
were comparable, indicating that binding vitamin
B12 to a surface did not lower catalytic activity.
No
loss in PCE reducing activity was observed with
repeated usage of surface-bound vitamin B12.
Carbon
mass recoveries were 81−84% for PCE reduction
and 89% for TCE reduction, relative to controls. In
addition to sequential hydrogenolysis, a second
competing reaction mechanism for the reduction of
PCE and TCE by B12, reductive β-elimination,
is
proposed to account for the observation of acetylene
as a significant reaction intermediate. Reductive
β-elimination should be considered as a potential
pathway in other reactive systems involving the
reduction of vicinal polyhaloethenes. Surface-bound
catalysts such as vitamin B12 may have utility in
the
engineered degradation of aqueous phase chlorinated
ethenes.
The novel complex (eta 6-benzylamine)tricarbonylchromium(0) 11 was prepared in up to 66% yield by direct complexation with Cr(CO)6 in refluxing 1,4-dioxane. Imine derivatives of this complex were readily deprotonated at the benzylic position by diamide 5, and the resultant anions reacted regioselectively with electrophiles (Me3SiCl or MeI) to give fairly good yields of products substituted at the benzylic carbon. Products of up to 87% e.e. were obtained in these reactions, with the highest enantioselectivity being derived from the tert-butyl-substituted imine complex 25.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.